Hansa Pink Sheet Technical Analysis

HNSBF Stock  USD 5.20  0.72  12.16%   
As of the 4th of February, Hansa Biopharma retains the market risk adjusted performance of (0.02582), and Risk Adjusted Performance of 0.0016. Hansa Biopharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed nineteen technical drivers for Hansa Biopharma AB, which can be compared to its competitors. Please check out Hansa Biopharma AB maximum drawdown, and the relationship between the information ratio and downside variance to decide if Hansa Biopharma is priced fairly, providing market reflects its last-minute price of 5.2 per share. Given that Hansa Biopharma AB has jensen alpha of (0.17), we strongly advise you to confirm Hansa Biopharma AB's regular market performance to make sure the company can sustain itself at a future point.

Hansa Biopharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Hansa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Hansa
Hansa Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Hansa Biopharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Hansa Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Hansa Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Hansa Biopharma AB Technical Analysis

Time Period
Execute Indicator
The output start index for this execution was thirty-four with a total number of output elements of twenty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Hansa Biopharma AB volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Hansa Biopharma AB Trend Analysis

Use this graph to draw trend lines for Hansa Biopharma AB. You can use it to identify possible trend reversals for Hansa Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Hansa Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Hansa Biopharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Hansa Biopharma AB applied against its price change over selected period. The best fit line has a slop of   0.024216  , which means Hansa Biopharma AB will continue generating value for investors. It has 122 observation points and a regression sum of squares at 22.18, which is the sum of squared deviations for the predicted Hansa Biopharma price change compared to its average price change.

About Hansa Biopharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Hansa Biopharma AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Hansa Biopharma AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Hansa Biopharma AB price pattern first instead of the macroeconomic environment surrounding Hansa Biopharma AB. By analyzing Hansa Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Hansa Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Hansa Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.

Hansa Biopharma February 4, 2023 Technical Indicators

Most technical analysis of Hansa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Hansa from various momentum indicators to cycle indicators. When you analyze Hansa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Please check Risk vs Return Analysis. Note that the Hansa Biopharma AB information on this page should be used as a complementary analysis to other Hansa Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Hansa Pink Sheet analysis

When running Hansa Biopharma AB price analysis, check to measure Hansa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hansa Biopharma is operating at the current time. Most of Hansa Biopharma's value examination focuses on studying past and present price action to predict the probability of Hansa Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Hansa Biopharma's price. Additionally, you may evaluate how the addition of Hansa Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Hansa Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Hansa Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hansa Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.